Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
lnk-754 (1 trial)
nv-5138 (1 trial)
Alzheimer Disease (Phase 1)
Depression (Phase 1)
Depressive Disorder (Phase 1)
Depressive Disorder, Treatment-Resistant (Phase 1)
Trials (2 total)
Trial APIs (2 total)